Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,411,033
-
Total 13F shares
-
49,438,743
-
Share change
-
-472,503
-
Total reported value
-
$3,041,039,173
-
Put/Call ratio
-
60%
-
Price per share
-
$61.75
-
Number of holders
-
80
-
Value change
-
+$30,510,281
-
Number of buys
-
40
-
Number of sells
-
32
Institutional Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q1 2021
As of 31 Mar 2021,
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,438,743 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LP, Bain Capital Life Sciences Investors, LLC, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, AJU IB Investment Co., Ltd., Rock Springs Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and Sectoral Asset Management Inc.
This page lists
79
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.